drugset / Trial / NCT03312894
Efficacy and Safety of TAK-653 in Treatment-Resistant Depression
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of TAK-653 compared with placebo in maintaining the effect of ketamine treatment on depressive symptoms.
Timeline
- Start
- 2018-02-15
- Primary completion
- 2019-02-28
- Completion
- 2019-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OSAVAMPATOR | Small molecule | 6 mg | Oral |
Indications
No indication recorded.